Related Experiment Video
Updated: Aug 9, 2026

Method for Simultaneous fMRI/EEG Data Collection during a Focused Attention Suggestion for Differential Thermal Sensation
Published on: January 5, 2014
The tacrolimus metabolism affect post-transplant outcome mediating acute rejection and delayed graft function:
Han Ro1, Jong Cheol Jeong2, Jin Min Kong3
1Department of Internal Medicine, Gil Hospital, Gachon University, Incheon, Korea.
Abstract:
Tacrolimus is a key drug in kidney transplantation (KT) with a narrow therapeutic index. The association between the tacrolimus metabolism rate and KT outcomes have not been investigated in large-scale multi-center studies. The Korean Organ Transplantation Registry (KOTRY) datasets were used. A total of 3456 KT recipients were analyzed. The tacrolimus metabolism rate was defined as blood trough concentration of tacrolimus (C0 ) divided by the daily dose (D). The patients were grouped into fast, intermediate, or slow metabolizers by the C0 /D measured 6 months after transplantation. The slow metabolism group was associated with a 2.7 ml/min/1.73 m2 higher adjusted estimated glomerular filtration rate (eGFR) at 6 months [95% confidence interval (C.I.) 1.2-4.3, P = 0.001], less acute rejection (AR) within 6 months [Odds ratio (OR) 0.744, 95% C.I. 0.585-0.947, P = 0.016], and less interstitial fibrosis and tubular atrophy [OR 0.606, 95% C.I. 0.390-0.940, P = 0.025]. Fast tacrolimus metabolism affected the 6-month post-KT eGFR through mediation of AR [natural indirect effect (NIE) -0.434, 95% C.I. -0.856 to -0.012, P = 0.044) and delayed graft function (DGF; NIE -0.119, 95% C.I. -0.231 to -0.007, P = 0.038). Slow tacrolimus metabolism was associated with better post-KT eGFR. AR and DGF were found to be significant mediators.
Insights
Slow tacrolimus metabolism in kidney transplant recipients is linked to better graft function and reduced rejection. Fast metabolism, however, can negatively impact outcomes through acute rejection and delayed graft function.
Area of Science:
- Nephrology
- Immunology
- Pharmacogenomics
Background:
- Tacrolimus is crucial for kidney transplantation (KT) but has a narrow therapeutic index.
- The relationship between tacrolimus metabolism rate and KT outcomes requires large-scale, multi-center investigation.
Purpose of the Study:
- To investigate the association between tacrolimus metabolism rate and kidney transplant outcomes.
- To analyze the impact of tacrolimus metabolism on estimated glomerular filtration rate (eGFR), acute rejection (AR), and interstitial fibrosis and tubular atrophy (IFTA).
Main Methods:
- Utilized Korean Organ Transplantation Registry (KOTRY) data from 3456 kidney transplant recipients.
- Defined tacrolimus metabolism rate as blood trough concentration (C0) divided by daily dose (D).
- Grouped patients into fast, intermediate, or slow metabolizers based on C0/D at 6 months post-transplant.
Main Results:
- Slow metabolizers showed a significantly higher adjusted eGFR (2.7 ml/min/1.73 m²), less AR (OR 0.744), and less IFTA (OR 0.606) at 6 months.
- Fast tacrolimus metabolism negatively impacted 6-month post-KT eGFR, mediated by AR and delayed graft function (DGF).
- AR and DGF were identified as significant mediators in the relationship between fast tacrolimus metabolism and eGFR.
Conclusions:
- Slow tacrolimus metabolism is associated with improved kidney transplant outcomes, including better graft function and reduced rejection.
- Understanding tacrolimus metabolism rates can help personalize immunosuppressive therapy to optimize kidney transplant success.
Related Concept Videos
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management
